These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29439357)

  • 21. Methods to monitor monocytes-mediated amyloid-beta uptake and phagocytosis in the context of adjuvanted immunotherapies.
    Hallé M; Tribout-Jover P; Lanteigne AM; Boulais J; St-Jean JR; Jodoin R; Girouard MP; Constantin F; Migneault A; Renaud F; Didierlaurent AM; Mallett CP; Burkhart D; Pilorget A; Palmantier R; Larocque D
    J Immunol Methods; 2015 Sep; 424():64-79. PubMed ID: 26002154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
    Hashimoto M; Rockenstein E; Crews L; Masliah E
    Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?
    Panza F; Logroscino G; Imbimbo BP; Solfrizzi V
    Curr Opin Psychiatry; 2014 Mar; 27(2):128-37. PubMed ID: 24445401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward.
    Panza F; Solfrizzi V; Imbimbo BP; Tortelli R; Santamato A; Logroscino G
    Expert Rev Clin Immunol; 2014 Mar; 10(3):405-19. PubMed ID: 24490853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Henry Dale and the discovery of acetylcholine.
    Tansey EM
    C R Biol; 2006; 329(5-6):419-25. PubMed ID: 16731499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylactic Vaccine Based on Pyroglutamate-3 Amyloid β Generates Strong Antibody Response and Rescues Cognitive Decline in Alzheimer's Disease Model Mice.
    Li G; Hu ZW; Chen PG; Sun ZY; Chen YX; Zhao YF; Li YM
    ACS Chem Neurosci; 2017 Mar; 8(3):454-459. PubMed ID: 28292186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Turning on a dime: the 75th anniversary of America's march against polio.
    Pederson T
    FASEB J; 2013 Jul; 27(7):2533-5. PubMed ID: 23824205
    [No Abstract]   [Full Text] [Related]  

  • 28. Potential biomarkers and novel pharmacological targets in protein aggregation-related neurodegenerative diseases.
    Giacomelli C; Daniele S; Martini C
    Biochem Pharmacol; 2017 May; 131():1-15. PubMed ID: 28159621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunotherapy of Alzheimer's disease. Results of experimental investigations and treatment of perspectives].
    Karkos J
    Fortschr Neurol Psychiatr; 2004 Apr; 72(4):204-19. PubMed ID: 15095177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gerald Cohen 1930-2001.
    Yahr MD
    Parkinsonism Relat Disord; 2002 Sep; 8(6):381-4. PubMed ID: 12356024
    [No Abstract]   [Full Text] [Related]  

  • 31. Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer's disease.
    Panza F; Frisardi V; Imbimbo BP; D'Onofrio G; Pietrarossa G; Seripa D; Pilotto A; Solfrizzi V
    Immunotherapy; 2010 Nov; 2(6):767-82. PubMed ID: 21091109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis.
    Boche D; Denham N; Holmes C; Nicoll JA
    Acta Neuropathol; 2010 Sep; 120(3):369-84. PubMed ID: 20632020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baicalein inhibits formation of α-synuclein oligomers within living cells and prevents Aβ peptide fibrillation and oligomerisation.
    Lu JH; Ardah MT; Durairajan SS; Liu LF; Xie LX; Fong WF; Hasan MY; Huang JD; El-Agnaf OM; Li M
    Chembiochem; 2011 Mar; 12(4):615-24. PubMed ID: 21271629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CCR 20th Anniversary Commentary: Chimeric Antigen Receptors-From Model T to the Tesla.
    Hwu P
    Clin Cancer Res; 2015 Jul; 21(14):3099-101. PubMed ID: 26180056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs.
    Forman MS; Trojanowski JQ; Lee VM
    Nat Med; 2004 Oct; 10(10):1055-63. PubMed ID: 15459709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotherapy in Alzheimer's disease: do we have all the pieces of the puzzle?
    Sarazin M; Dorothée G; de Souza LC; Aucouturier P
    Biol Psychiatry; 2013 Sep; 74(5):329-32. PubMed ID: 23683656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropathology of synuclein aggregates.
    Duda JE; Lee VM; Trojanowski JQ
    J Neurosci Res; 2000 Jul; 61(2):121-7. PubMed ID: 10878583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1932-2007: our 75th anniversary year.
    Smith HF
    Psychoanal Q; 2007 Jan; 76(1):1-7. PubMed ID: 17294821
    [No Abstract]   [Full Text] [Related]  

  • 39. Drosophila melanogaster: a fly through its history and current use.
    Stephenson R; Metcalfe NH
    J R Coll Physicians Edinb; 2013; 43(1):70-5. PubMed ID: 23516695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders.
    Mollenhauer B; Parnetti L; Rektorova I; Kramberger MG; Pikkarainen M; Schulz-Schaeffer WJ; Aarsland D; Svenningsson P; Farotti L; Verbeek MM; Schlossmacher MG
    J Neurochem; 2016 Oct; 139 Suppl 1():290-317. PubMed ID: 26452984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.